PIONEER III
STUDY IDENTIFIER:
PIONEER III
CONDITION:
Coronary Artery Disease
CONTACT INFO:
Amber Antos-Mellang | amber.antos@allina.com | 612-863-8098
DESCRIPTION:
The primary objective of this trial is to compare the safety and efficacy of the SINOMED BuMA Supreme biodegradable coronary stent in patients with up to 3 coronary lesions to either the XIENCE or Promus durable polymer coronary stents.
CRITERIA LIST/ QUALIFICATIONS:
- The patient is an acceptable candidate for percutaneous coronary intervention (PCI) with drug-eluting stents
INVESTIGATORS:
M. Nicholas Burke, MD
SPONSORS:
SINOMED / US Subsidiary: NOVA Vascular, LLC
STATUS:
Open/Enrolling